BGLC logo

BioNexus Gene Lab Corp. (BGLC)

Profile

Full Name

BioNexus Gene Lab Corp.

Ticker

NASDAQ: BGLC

Exchange

NASDAQ

Sector

Basic Materials

Industry

Specialty Chemicals

Country

Malaysia

IPO

January 8, 2021

Indexes

Not included

Website

https://www.bionexusgenelab.com

Employees

30

Key Details

Price

$5.29(-0.75%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.51M(-2.66% YoY)

Annual EPS

-$0.90(+45.78% YoY)

PE ratio

-

Next earnings date

Aug 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.29
    BGLC price is $5.29

    30-Day Relative Volume

    1.09
    BGLC 30-day relative volume is 1.09

    Price Performance

    Price Today change

    -0.75%
    BGLC price is down -0.75% today

    Price YTD change

    +88.93%
    BGLC price is up +88.93% since January 1st

    Price 1-year change

    +21.89%
    BGLC price is up +21.89% year-on-year

    Price 3-year change

    -96.2%
    BGLC price is down -96.2% over the past 3 years

    Price Range

    Price All-time high

    $322.80
    BGLC price is currently -98.36% below its historical high of $322.80

    Price 3-year low

    $2.01
    BGLC price is currently +163.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.50M
    BGLC market capitalization is $9.50 million

    Market cap 3-year change

    -95.28%
    BGLC market capitalization is down -95.28% over the past 3 years

    Market cap All-time high

    $407.49M
    BGLC market capitalization is currently -97.67% below its historical high of $407.49 million

    Market cap sector rank

    4.61%
    BGLC market capitalization is higher than 4.61% of companies in Basic Materials sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.01%
    BGLC shares outstanding is down -0.01% year-on-year

    Shares Outstanding 3-Year Change

    +24.1%
    BGLC shares outstanding is up +24.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.12
    BGLC beta is 0.12

    200-day SMA

    $3.59
    BGLC price is currently +47.20% above its 200-day simple moving average

    50-day SMA

    $4.89
    BGLC price is currently +8.10% above its 50-day simple moving average

    RSI

    49.48
    BGLC 14-day relative strength index is 49.48

    Volume

    1.09
    BGLC 30-day relative volume is 1.09

    ATR

    $0.55
    BGLC average true range is $0.55

    10-day Historical Volatility

    46.45%
    BGLC 10-day historical volatility is 46.45%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.51M
    BGLC annual revenue is $9.51 million

    Revenue Analysts estimate

    -
    BGLC annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -2.66%
    BGLC annual revenue is down -2.66% year-on-year

    Revenue Sector rank

    24.82%
    BGLC annual revenue is higher than 24.82% of companies in Basic Materials sector

    EPS

    EPS

    -$0.90
    BGLC annual earnings per share is -$0.90

    EPS Analysts estimate

    -
    BGLC annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +45.78%
    BGLC annual earnings per share is up +45.78% year-on-year

    EPS Sector rank

    18.31%
    BGLC annual earnings per share is higher than 18.31% of companies in Basic Materials sector

    Profit

    Gross profit

    $1.19M
    BGLC annual gross profit is $1.19 million

    Gross margin

    12.46%
    BGLC annual gross profit margin is 12.46%

    Operating profit

    -$1.96M
    BGLC annual operating income is -$1.96 million

    Operating margin

    -20.57%
    BGLC annual operating profit margin is -20.57%

    Net income

    -$1.60M
    BGLC annual net profit is -$1.60 million

    Net margin

    -16.81%
    BGLC annual net profit margin is -16.81%

    Expenses

    Total expenses

    $11.11M
    BGLC annual total expenses is $11.11 million

    Operating expenses

    $3.14M
    BGLC annual total operating expenses is $3.14 million

    Cost of goods sold

    $8.33M
    BGLC annual cost of goods sold is $8.33 million

    Selling, general & administrative expenses

    $0.00
    BGLC annual SGA is $0.00

    Depreciation and amortization

    $153.10K
    BGLC annual depreciation & amortization is $153.10 thousand

    Interest expense

    $0.00
    BGLC annual interest expense is $0.00

    Income tax

    $3500.00
    BGLC annual income tax is $3500.00

    EBIT & EBITDA

    EBIT

    -$1.96M
    BGLC annual earnings before interest & taxes is -$1.96 million

    EBITDA

    -$1.80M
    BGLC annual EBITDA is -$1.80 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $10.43M
    BGLC annual total assets is $10.43 million

    Non current assets

    $3.00M
    BGLC annual long term assets is $3.00 million

    Current assets

    $7.43M
    BGLC annual total current assets is $7.43 million

    Cash and cash equivalents

    $4.38M
    BGLC annual cash & cash equivalents is $4.38 million

    Accounts receivable

    $1.38M
    BGLC annual accounts receivable is $1.38 million

    Inventory

    $1.39M
    BGLC annual inventory is $1.39 million

    Liabilities

    Total liabilities

    $2.11M
    BGLC annual total liabilities is $2.11 million

    Long term liabilities

    $159.70K
    BGLC annual total long term liabilities is $159.70 thousand

    Current liabilities

    $1.95M
    BGLC annual total current liabilities is $1.95 million

    Accounts payable

    $1.50M
    BGLC annual accounts payable is $1.50 million

    Debt

    Total debt

    $210.50K
    BGLC annual total debt is $210.50 thousand

    Total debt 1-year change

    +57.8%
    BGLC annual total debt is up +57.8% year-on-year

    Long term debt

    $159.70K
    BGLC annual long term debt is $159.70 thousand

    Short term debt

    $50.80K
    BGLC annual short term debt is $50.80 thousand

    Equity & Capital

    Shareholders equity

    $8.32M
    BGLC annual stockholders equity is $8.32 million

    Book value

    $8.32M
    BGLC annual book value is $8.32 million

    Retained earnings

    -$3.44M
    BGLC annual retained earnings is -$3.44 million

    Working capital

    $5.48M
    BGLC annual working capital is $5.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$2.17M
    BGLC annual cash flow from operations is -$2.17 million

    Cash from operations 1-year change

    -23.02%
    BGLC annual cash flow from operations is down -23.02% year-on-year

    Cash from investing

    $350.10K
    BGLC annual cash flow from investing activities is $350.10 thousand

    Cash from investing 1-year change

    +118.87%
    BGLC annual cash flow from investing activities is up +118.87% year-on-year

    Cash from financing

    $145.00K
    BGLC annual cash flow from financing activities is $145.00 thousand

    Cash from financing 1-year change

    -97.69%
    BGLC annual cash flow from financing activities is down -97.69% year-on-year

    CAPEX

    CAPEX

    $227.00K
    BGLC annual capital expenditures is $227.00 thousand

    CAPEX 1-year change

    +51.94%
    BGLC annual capital expenditures is up +51.94% year-on-year

    Free Cash Flow

    Free cash flow

    -$2.39M
    BGLC annual free cash flow is -$2.39 million

    Free cash flow 1-year change

    -25.28%
    BGLC annual free cash flow is down -25.28% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    12.46%
    BGLC annual gross profit margin is 12.46%

    Operating margin

    -20.57%
    BGLC annual operating profit margin is -20.57%

    Net margin

    -16.81%
    BGLC annual net profit margin is -16.81%

    ROA & ROE

    ROA

    -14.64%
    BGLC annual return on assets is -14.64%

    ROE

    -17.78%
    BGLC annual return on equity is -17.78%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BGLC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BGLC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.26
    BGLC price to book ratio is 1.26

    PB ratio Sector rank

    38.79%
    BGLC price to book ratio is higher than 38.79% of companies in Basic Materials sector

    PS Ratio

    PS ratio

    1.00
    BGLC price to sales ratio is 1.00

    PS ratio Sector rank

    35.85%
    BGLC price to sales ratio is higher than 35.85% of companies in Basic Materials sector

    Enterprise value

    Enterprise value

    $6.64M
    BGLC enterprise value is $6.64 million

    Enterprise value Sector rank

    2.85%
    BGLC enterprise value is higher than 2.85% of companies in Basic Materials sector

    EV/EBITDA

    EV/EBITDA

    -2.83
    BGLC EV/EBITDA is -2.83

    EV/EBITDA Sector rank

    27.91%
    BGLC EV/EBITDA is higher than 27.91% of companies in Basic Materials sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.81
    BGLC annual current ratio is 3.81

    Quick ratio

    3.10
    BGLC annual quick ratio is 3.10

    Leverage

    Debt to equity

    0.03
    BGLC annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    BGLC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    BGLC piotroski f-score is 3

    Altman Z-Score

    3.16
    BGLC altman z-score is 3.16

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with BGLC included

    Basic materials sector
    Best performing stocks last 3 months
    Earnings today
    NASDAQ Dividend Calendar
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    Companies with buyback
    Earnings this week
    Best performing stocks YTD
    • What is the ticker symbol for BioNexus Gene Lab Corp.?
    • Does BioNexus Gene Lab Corp. pay dividends?
    • What sector is BioNexus Gene Lab Corp. in?
    • What industry is BioNexus Gene Lab Corp. in?
    • What country is BioNexus Gene Lab Corp. based in?
    • When did BioNexus Gene Lab Corp. go public?
    • Is BioNexus Gene Lab Corp. in the S&P 500?
    • Is BioNexus Gene Lab Corp. in the NASDAQ 100?
    • Is BioNexus Gene Lab Corp. in the Dow Jones?
    • When was BioNexus Gene Lab Corp.'s last earnings report?
    • When does BioNexus Gene Lab Corp. report earnings?

    What is the ticker symbol for BioNexus Gene Lab Corp.?

    The ticker symbol for BioNexus Gene Lab Corp. is NASDAQ:BGLC

    Does BioNexus Gene Lab Corp. pay dividends?

    No, BioNexus Gene Lab Corp. does not pay dividends

    What sector is BioNexus Gene Lab Corp. in?

    BioNexus Gene Lab Corp. is in the Basic Materials sector

    What industry is BioNexus Gene Lab Corp. in?

    BioNexus Gene Lab Corp. is in the Specialty Chemicals industry

    What country is BioNexus Gene Lab Corp. based in?

    BioNexus Gene Lab Corp. is headquartered in Malaysia

    When did BioNexus Gene Lab Corp. go public?

    BioNexus Gene Lab Corp.'s initial public offering (IPO) was on January 8, 2021

    Is BioNexus Gene Lab Corp. in the S&P 500?

    No, BioNexus Gene Lab Corp. is not included in the S&P 500 index

    Is BioNexus Gene Lab Corp. in the NASDAQ 100?

    No, BioNexus Gene Lab Corp. is not included in the NASDAQ 100 index

    Is BioNexus Gene Lab Corp. in the Dow Jones?

    No, BioNexus Gene Lab Corp. is not included in the Dow Jones index

    When was BioNexus Gene Lab Corp.'s last earnings report?

    BioNexus Gene Lab Corp.'s most recent earnings report was on May 15, 2025

    When does BioNexus Gene Lab Corp. report earnings?

    The next expected earnings date for BioNexus Gene Lab Corp. is August 21, 2025
    On this page